Here, our patient 1 with monoallelic CYP24A1 variant presented symptomatic hypercalcemia in infancy, providing a clinical reference for the view of the potential risk of developing hypercalcemia and related clinical manifestations if exposed to triggering factors [18]. This evidence concerns the gene CYP24A1 and hypercalcemia disease.